Business & Regulation

Sitting Down With… Elaine O’Hara, Chief Commercial Officer at Sanofi Pasteur.

We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis.

Power testing partnership, NASH breakthrough designation, and new CEO appointments. What’s new for pharma in business?

Sitting Down With... Kimberly Eggers, Vice-president of Medical and Clinical Affairs at Aprecia.

QC must evolve to meet progress in biopharmaceutical manufacturing.

Looking back at Trump’s tenure, and the potential implications of the US elections for pharma and the Affordable Health Act.

Graeme Dennis questions why the industry refuses to make use of the significant amount of data it generates.

How is African pharma coping with the COVID-19 pandemic?

What can African nations do to retain the talent necessary for building pharmaceutical infrastructure?

Can the African Medicines Agency be mobilized quickly enough to respond to the needs of the pharmaceutical sector?